Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin)

Carcinogenesis

Volumn 26, Issue 8, 2005, Pages 1450-1456

  Volate, Suresh R ^a   Davenport, Destiny M ^a   Muga, Stephanie J ^a   Wargovich, Michael J ^a  

^a South Carolina Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CASPASE 9; CURCUMIN; GINSENG EXTRACT; INDOMETACIN; PROTEIN BAX; PROTEIN BCL 2; QUERCETIN; RUTOSIDE; SILYMARIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARCINOGEN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; COLON BIOPSY; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CORRELATION FUNCTION; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; FEEDING; HISTOPATHOLOGY; INTESTINE CRYPT; MALE; MAXIMUM TOLERATED DOSE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ANIMAL; COLON TUMOR; DISEASE MODEL; DRUG EFFECT; FISCHER 344 RAT; GINSENG; INTESTINE MUCOSA; PATHOLOGY;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; INTESTINAL MUCOSA; MALE; PANAX; PLANT EXTRACTS; QUERCETIN; RATS; RATS, INBRED F344; RUTIN; SILYMARIN;

EID: 24944522546     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi089     Document Type: Article

References (29)

1. Jemal,A., Tiwari,R.C., Murray,T., Ghafoor,A., Samuels,A., Ward,E., Feuer,E.J. and Thun,M.J. (2004) Cancer statistics, 2004. CA Cancer J. Clin., 54, 8-29.
2. Kelloff,G.J., Crowell,J.A., Steele,V.E. et al. (2000) Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents. J. Nutr., 130, 467S-471S.
3. Mahmoud,N.N., Carothers,A.M., Grünberger,D., Bilinski,R.T., Churchill,M.R., Martucci,C., Newmark,H.L. and Bertagnolli,M.M. (2000) Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis, 21, 921-927.
4. Mutoh,M., Takahashi,M., Fukuda,K., Komatsu,H., Enya,T., Matsushima-Hibiya,Y., Mutoh,H., Sugimura,T. and Wakabayashi,K. (2000) Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: Structure-activity relationship. Jpn. J. Cancer Res., 91, 686-691.
5. Wenzel,U., Kuntz,S., Brendel,M.D. and Daniel,H. (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res., 60, 3823-3831.
6. Ludbrook,J. (1998) Multiple comparison procedures updated. Clin. Exp. Pharmacol. Physiol., 25, 1032-1037.
7. Brown,W.A., Skinner,S.A., Malcontenti-Wilson,C., Misajon,A., DeJong,T., Vogiagis,D. and O'Brien,P.E. (2000) Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model. J. Gastroenterol. Hepatol., 15, 1386-1392.
8. Pretlow,T.P., O'Riordan,M.A., Somich,G.A., Amini,S.B. and Pretlow,T.G. (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512.
9. Furukawa,F., Nishikawa,A., Kitahori,Y., Tanakamaru,Z. and Hirose,M. (2002) Spontaneous development of aberrant crypt foci in F344 rats. J. Exp. Clin. Cancer Res., 21, 197-201.
10. Rodrigues,M.A., Silva,L.A., Salvadori,D.M., De Camargo,J.L. and Montenegro,M.R. (2002) Aberrant crypt foci and colon cancer: Comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz. J. Med. Biol. Res., 35 351-355.
11. Fukushima,S., Wanibuchi,H. and Li,W. (2001) Inhibition by ginseng of colon carcinogenesis in rats. J. Korean Med. Sci., 16 (Suppl), S75-S80.
12. Li,W., Wanibuchi,H., Salim,E.I., Wei,M., Yamamoto,S., Nishino,H. and Fukushima,S. (2000) Inhibition by ginseng of 1,2-dimethylhydrazine induction of aberrant crypt foci in the rat colon. Nutr. Cancer, 36, 66-73.
13. Kawamori,T., Lubet,R., Steele,V.E., Kelloff,G.J., Kaskey,R.B., Rao,C.V. and Reddy,B.S. (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res., 59, 597-601.
14. Kohno,H., Tanaka,T., Kawabata,K., Hirose,Y., Sugie,S., Tsuda,H. and Mori,H. (2002) Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int. J. Cancer, 101, 461-468.
15. Tao,L., Kramer,P.M., Wang,W., Yang,S., Lubet,R.A., Steele,V.E. and Pereira,M.A. (2002) Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. Carcinogenesis, 23, 1447-1454.
16. Roncucci,L., Pedroni,M., Fante,R., Di Gregorio,C. and Ponz de Leon,M. (1993) Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). Cancer Res., 53, 3726-3729.
17. Dashwood,R.H., Xu,M., Orner,G.A. and Horio,D.T. (2001) Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidaz. Eur. J. Cancer Prev., 10, 139-145.
18. McLellan,E.A., Medline,A. and Bird,R.P. (1991) Dose response and proliferative characteristics of aberrant crypt foci: Putative preneoplastic lesions in rat colon. Carcinogenesis, 12, 2093-2098.
19. Siu,I.M., Robinson,D.R., Schwartz,S., Kung,H.J., Pretlow,T.G., Petersen,R.B. and Pretlow,T.P. (1999) The identification of monoclonality in human aberrant crypt foci. Cancer Res., 59, 63-66.
20. Mori,H., Yamada,Y., Hirose,Y., Kuno,T., Katayama,M., Sakata,K., Yoshida,K., Sugie,S., Hara,A. and Yoshimi,N. (2002) Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker. Eur. J. Cancer Prev., 11(Suppl 2), S71-S75.
21. Caderni,G., Femia,A.P., Giannini,A., Favuzza,A., Luceri,C., Salvadori,M. and Dolara,P. (2003) Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: Correlation with carcinogenesis. Cancer Res., 63, 2388-2392.
22. Wargovich,M.J., Harris,C., Chen,C.D., Palmer,C., Steele,V.E. and Kelloff,G.J. (1992) Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J. Cell Biochem. Suppl., 16(G), 51-54.
23. Wargovich,M.J., Chen,C.D., Jimenez,A., Steele,V.E., Velasco,M., Stephens,L.C., Price,R., Gray,K. and Kelloff,G.J. (1996) Aberrant crypts as a biomarker for colon cancer: Evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev., 5, 355-360.
24. Yang,K., Lamprecht,S.A., Liu,Y., Shinozaki,H., Fan,K., Leung,D., Newmark,H., Steele,V.E., Kelloff,G.J. and Lipkin,M. (2000) Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis, 21, 1655-1660.
25. Hollman,P.C., de Vries,J.H., van Leeuwen,S.D., Mengelers,M.J. and Katan,M.B. (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr., 62, 1276-1282.
26. Agarwal,C., Singh,R.P., Dhanalakshmi,S., Tyagi,A.K., Tecklenburg,M., Sclafani,R.A. and Agarwal,R. (2003) Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene, 22 8271-8282.
27. Sato,M. and Ahnen,D.J. (1992) Regional variability of colonocyte growth and differentiation in the rat. Anat. Rec., 233, 409-414.
28. Miura,Y.H., Tomita,I., Watanabe,T., Hirayama,T. and Fukui,S. (1998) Active oxygens generation by flavonoids. Biol. Pharm. Bull., 21 93-96.
29. Ruby,A.J., Kuttan,G., Babu,K.D., Rajasekhavan,K.N., Kuttan,R. (1995) Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett., 94, 79-83.